Literature DB >> 18753675

Chylomicron remnants are increased in the postprandial state in CD36 deficiency.

Daisaku Masuda1, Ken-ichi Hirano, Hiroyuki Oku, Jose C Sandoval, Ryota Kawase, Miyako Yuasa-Kawase, Yasushi Yamashita, Masanori Takada, Kazumi Tsubakio-Yamamoto, Yoshihiro Tochino, Masahiro Koseki, Fumihiko Matsuura, Makoto Nishida, Toshiharu Kawamoto, Masato Ishigami, Masatsugu Hori, Iichiro Shimomura, Shizuya Yamashita.   

Abstract

The clustering of risk factors including dyslipidemia, hyperglycemia, and hypertension is highly atherogenic along with the excess of remnants from triglyceride (TG)-rich lipoproteins. CD36 is involved in the uptake of long-chain fatty acids (LCFAs) in muscles and small intestines. Patients with CD36 deficiency (CD36-D) have postprandial hypertriglyceridemia, insulin resistance, and hypertension. To investigate the underlying mechanism of postprandial hypertriglyceridemia in CD36-D, we analyzed lipoprotein profiles of CD36-D patients and CD36-knockout (CD36-KO) mice after oral fat loading (OFL). In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free glycerol levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles. In CD36-KO mice, lipoproteins smaller than CM in size in plasma and intestinal lymph were markedly increased after OFL and mRNA levels of genes involved in FFA biosynthesis, such as fatty acid binding protein (FABP)-1 and FAS, were significantly increased. These results suggest that CD36-D might increase atherosclerotic risk by enhancing plasma level of CM remnants due to the increased synthesis of lipoproteins smaller than CM in size in the intestine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753675      PMCID: PMC2666186          DOI: 10.1194/jlr.P700032-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

1.  Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism.

Authors:  Takahiro Kuwasako; Ken-ichi Hirano; Naohiko Sakai; Masato Ishigami; Hisatoyo Hiraoka; Mohamed Janabi Yakub; Keiko Yamauchi-Takihara; Shizuya Yamashita; Yuji Matsuzawa
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese.

Authors:  S Kajihara; A Hisatomi; Y Ogawa; T Yasutake; T Yoshimura; T Hara; T Mizuta; I Ozaki; N Iwamoto; K Yamamoto
Journal:  Clin Chim Acta       Date:  2001-12       Impact factor: 3.786

3.  Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.

Authors:  Matteo Pirro; Pascale Mauriège; André Tchernof; Bernard Cantin; Gilles R Dagenais; Jean Pierre Després; Benoît Lamarche
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

4.  CD36 deficiency associated with insulin resistance.

Authors:  K Miyaoka; T Kuwasako; K Hirano; S Nozaki; S Yamashita; Y Matsuzawa
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

5.  Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly.

Authors:  J Luchoomun; M M Hussain
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

6.  Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease.

Authors:  Mitsuyo Okazaki; Shinichi Usui; Akio Fukui; Isao Kubota; Hitonobu Tomoike
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

7.  High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease.

Authors:  M Carlsson; Y Wessman; P Almgren; L Groop
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

8.  Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.

Authors:  E P Lutz; M Merkel; Y Kako; K Melford; H Radner; J L Breslow; A Bensadoun; I J Goldberg
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

9.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

10.  Development of a homogeneous assay to measure remnant lipoprotein cholesterol.

Authors:  Kazuhito Miyauchi; Norihiko Kayahara; Masato Ishigami; Hideyuki Kuwata; Hideharu Mori; Hiroyuki Sugiuchi; Tetsumi Irie; Akira Tanaka; Shizuya Yamashita; Taku Yamamura
Journal:  Clin Chem       Date:  2007-09-27       Impact factor: 8.327

View more
  37 in total

Review 1.  Dietary Lipids Inform the Gut and Brain about Meal Arrival via CD36-Mediated Signal Transduction.

Authors:  Sinju Sundaresan; Nada A Abumrad
Journal:  J Nutr       Date:  2015-08-12       Impact factor: 4.798

2.  Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis.

Authors:  Peixiang Zhang; Lauren S Csaki; Emilio Ronquillo; Lynn J Baufeld; Jason Y Lin; Alexis Gutierrez; Jennifer R Dwyer; David N Brindley; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

3.  Micellar lipid composition affects micelle interaction with class B scavenger receptor extracellular loops.

Authors:  Aurélie Goncalves; Brigitte Gontero; Marion Nowicki; Marielle Margier; Gabriel Masset; Marie-Josèphe Amiot; Emmanuelle Reboul
Journal:  J Lipid Res       Date:  2015-04-01       Impact factor: 5.922

Review 4.  New insights into the molecular mechanism of intestinal fatty acid absorption.

Authors:  Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-09-18       Impact factor: 4.686

Review 5.  Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism.

Authors:  Marta Yanina Pepino; Ondrej Kuda; Dmitri Samovski; Nada A Abumrad
Journal:  Annu Rev Nutr       Date:  2014-05-16       Impact factor: 11.848

Review 6.  CD36 genetics and the metabolic complications of obesity.

Authors:  Latisha Love-Gregory; Nada A Abumrad
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-11       Impact factor: 4.294

7.  Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.

Authors:  Satoshi Yamaguchi; Bo Zhang; Takeshi Tomonaga; Utako Seino; Akiko Kanagawa; Masaru Segawa; Hironori Nagasaka; Akira Suzuki; Takashi Miida; Sohsuke Yamada; Yasuyuki Sasaguri; Takefumi Doi; Keijiro Saku; Mitsuyo Okazaki; Yoshihiro Tochino; Ken-Ichi Hirano
Journal:  J Lipid Res       Date:  2014-02-25       Impact factor: 5.922

Review 8.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 9.  Cellular fatty acid uptake: a pathway under construction.

Authors:  Xiong Su; Nada A Abumrad
Journal:  Trends Endocrinol Metab       Date:  2009-01-29       Impact factor: 12.015

10.  Associations between CD36 gene polymorphisms, fat tolerance and oral fat preference in a young-adult population.

Authors:  A F Jayewardene; Y Mavros; D P Hancock; T Gwinn; K B Rooney
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.